US5151439A
(en)
*
|
1990-05-04 |
1992-09-29 |
American Cyanamid Company |
Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
|
US5089514A
(en)
*
|
1990-06-14 |
1992-02-18 |
Pfizer Inc. |
3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
|
TW222626B
(he)
|
1991-07-22 |
1994-04-21 |
Pfizer |
|
US5498621A
(en)
*
|
1992-05-01 |
1996-03-12 |
Pfizer Inc. |
Oxazolidinedione hypoglycemic agents
|
AU678974B2
(en)
*
|
1992-07-03 |
1997-06-19 |
Smithkline Beecham Plc |
Heterocyclic compounds as pharmaceutical
|
US5232945A
(en)
*
|
1992-07-20 |
1993-08-03 |
Pfizer Inc. |
3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
|
GB9225386D0
(en)
*
|
1992-12-04 |
1993-01-27 |
Smithkline Beecham Plc |
Novel compounds
|
GB9311661D0
(en)
*
|
1993-06-05 |
1993-07-21 |
Smithkline Beecham Plc |
Novel compounds
|
GB9311644D0
(en)
*
|
1993-06-05 |
1993-07-21 |
Smithkline Beecham Plc |
Novel compounds
|
GB9315148D0
(en)
*
|
1993-07-22 |
1993-09-08 |
Smithkline Beecham Plc |
Novel compounds
|
GB9326171D0
(en)
*
|
1993-12-22 |
1994-02-23 |
Smithkline Beecham Plc |
Novel compounds
|
WO1996004261A1
(en)
*
|
1994-07-29 |
1996-02-15 |
Smithkline Beecham Plc |
Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
|
US5827865A
(en)
*
|
1995-03-09 |
1998-10-27 |
Smithkline Beecham P.L.C. |
Heterocyclic compounds as pharmaceutical
|
GB9604242D0
(en)
*
|
1996-02-28 |
1996-05-01 |
Glaxo Wellcome Inc |
Chemical compounds
|
CZ318098A3
(cs)
*
|
1996-04-04 |
1999-01-13 |
Sankyo Company, Limited |
Deriváty fenylalkylkarboxylové kyseliny, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
|
EP0925063A4
(en)
*
|
1996-07-01 |
2000-12-27 |
Lilly Co Eli |
Blood-glucose-lowering and lipid-lowering compounds
|
CA2259431A1
(en)
*
|
1996-07-01 |
1998-01-08 |
Eli Lilly And Company |
Hypoglycemic and hypolipidemic compounds
|
CZ53699A3
(cs)
|
1996-08-19 |
1999-07-14 |
Japan Tobacco Inc. |
Deriváty propionové kyseliny a jejich použití
|
US6090839A
(en)
*
|
1996-12-23 |
2000-07-18 |
Merck & Co., Inc. |
Antidiabetic agents
|
US6160000A
(en)
*
|
1996-12-23 |
2000-12-12 |
Merck & Co., Inc. |
Antidiabetic agents based on aryl and heteroarylacetic acids
|
EP0994095A1
(en)
*
|
1996-12-24 |
2000-04-19 |
Nippon Chemiphar Co., Ltd. |
Propionic acid derivatives
|
EA003025B1
(ru)
|
1997-06-18 |
2002-12-26 |
Смитклайн Бичам Плс |
Лечение диабета тиазолидиндионом и сульфонилмочевиной
|
ES2200248T3
(es)
*
|
1997-09-19 |
2004-03-01 |
Ssp Co., Ltd. |
Derivados de acudi fenilpropionico sustituido en alfa y medicamento que los contienen.
|
ID24376A
(id)
|
1997-10-02 |
2000-07-13 |
Sankyo Co |
Turunan-turunan asam amidokarboksilat
|
WO1999016758A1
(en)
*
|
1997-10-27 |
1999-04-08 |
Dr. Reddy's Research Foundation |
Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
CA2307068C
(en)
|
1997-10-27 |
2007-04-10 |
Dr. Reddy's Research Foundation |
Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
WO1999020614A1
(en)
*
|
1998-05-27 |
1999-04-29 |
Dr. Reddy's Research Foundation |
Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
US6369067B1
(en)
|
1997-10-27 |
2002-04-09 |
Dr. Reddy's Research Foundation |
Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
GB2364304B
(en)
*
|
1997-10-27 |
2003-04-23 |
Reddy Research Foundation |
Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
|
US6265401B1
(en)
|
1997-10-27 |
2001-07-24 |
Reddy-Cheminor, Inc. |
Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
US6444816B1
(en)
|
1997-10-27 |
2002-09-03 |
Dr. Reddy's Research Foundation |
Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
|
EP1051403A1
(en)
*
|
1998-01-29 |
2000-11-15 |
Dr. Reddy's Research Foundation |
Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
US6166069A
(en)
*
|
1998-05-12 |
2000-12-26 |
American Home Products Corporation |
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
CA2331120A1
(en)
*
|
1998-05-12 |
1999-11-18 |
Iwan Gunawan |
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
MA26634A1
(fr)
|
1998-06-04 |
2004-12-20 |
Astra Ab |
Nouveaux derives de l'acide 3-aryl propionique et analogues
|
SE9801992D0
(sv)
|
1998-06-04 |
1998-06-04 |
Astra Ab |
New 3-aryl-2-hydroxypropionic acid derivative I
|
US7045519B2
(en)
*
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
WO1999065897A1
(en)
|
1998-06-19 |
1999-12-23 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
GB9817118D0
(en)
|
1998-08-07 |
1998-10-07 |
Glaxo Group Ltd |
Pharmaceutical compounds
|
US6664281B1
(en)
|
1998-08-27 |
2003-12-16 |
Ono Pharmaceutical Co., Ltd. |
Carboxylic acid derivatives and drugs containing the same as the active ingredient
|
US6589969B1
(en)
|
1998-10-16 |
2003-07-08 |
Ono Pharmaceutical Co., Ltd. |
Carboxylic acid derivatives and drugs containing the same as the active ingredient
|
AR023700A1
(es)
|
1998-11-12 |
2002-09-04 |
Smithkline Beecham Plc |
Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
|
SK287038B6
(sk)
|
1998-11-12 |
2009-10-07 |
Smithkline Beecham Plc |
Farmaceutický prostriedok na postupné uvoľňovanie 5-[4-[2-(N- metyl-N-(2-pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu a metformínu a spôsob jeho výroby
|
WO2000063189A1
(en)
*
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
|
US6528507B1
(en)
|
1999-04-16 |
2003-03-04 |
Dr. Reddy's Laboratories Limited |
Polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
|
BR0010683A
(pt)
*
|
1999-04-16 |
2003-07-01 |
Reddy Research Foundation |
Formas polimórficas de um agente antidiabético: processo para seu preparo e composições farmacêuticas contendo o mesmo
|
US6972294B1
(en)
|
1999-04-20 |
2005-12-06 |
Novo Nordisk, A/S |
Compounds, their preparation and use
|
CA2375843A1
(en)
*
|
1999-06-04 |
2000-12-14 |
Qi Zhao |
Compositions and methods for inhibiting cell death
|
WO2001011072A1
(en)
*
|
1999-08-05 |
2001-02-15 |
Novo Nordisk A/S |
Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids
|
US6541495B1
(en)
|
1999-08-27 |
2003-04-01 |
Pfizer |
Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
|
WO2001016111A2
(en)
|
1999-08-27 |
2001-03-08 |
Eli Lilly And Company |
Hypoglycemic sulfonyl pyrazolones and pyrazolines
|
US6417212B1
(en)
|
1999-08-27 |
2002-07-09 |
Eli Lilly & Company |
Modulators of peroxisome proliferator activated receptors
|
BRPI0108024B8
(pt)
*
|
2000-01-19 |
2021-05-25 |
Cadila Healthcare Ltd |
composto, processo para a preparação de um composto, composição farmacêutica, uso do composto, novo intermediário e processo para a preparação de um novo intermediário
|
US6555577B1
(en)
|
2000-01-28 |
2003-04-29 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
GB0002667D0
(en)
*
|
2000-02-04 |
2000-03-29 |
Glaxo Group Ltd |
medicamesnts
|
US6509374B2
(en)
|
2000-04-17 |
2003-01-21 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6908908B2
(en)
|
2000-05-12 |
2005-06-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Biologically active 4H-benzo [1,4] oxazin-3-ones
|
DK1280784T3
(da)
*
|
2000-05-12 |
2007-10-29 |
Ortho Mcneil Pharm Inc |
Biologisk aktive 4H-benzo[1,4]oxazin-3-oner
|
WO2001087861A2
(en)
*
|
2000-05-12 |
2001-11-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
|
AU2001259747A1
(en)
|
2000-05-12 |
2001-11-26 |
Ortho-Mcneil Pharmaceutical, Inc. |
Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
EP1313715B1
(en)
*
|
2000-08-23 |
2007-08-01 |
Eli Lilly And Company |
Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
|
AU2001284660A1
(en)
*
|
2000-08-23 |
2002-03-04 |
Eli Lilly And Company |
Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
|
CA2418104A1
(en)
*
|
2000-08-23 |
2002-02-28 |
Eli Lilly And Company |
Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
|
IL158589A0
(en)
|
2001-05-15 |
2004-05-12 |
Hoffmann La Roche |
Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
|
PL368051A1
(en)
|
2001-06-07 |
2005-03-21 |
Eli Lilly And Company |
Modulators of peroxisome proliferator activated receptors
|
JP2005502600A
(ja)
*
|
2001-06-07 |
2005-01-27 |
イーライ・リリー・アンド・カンパニー |
ペルオキシソーム増殖因子活性化受容体(ppar)のモジュレーター
|
US6987123B2
(en)
*
|
2001-07-26 |
2006-01-17 |
Cadila Healthcare Limited |
Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
|
US20030055076A1
(en)
*
|
2001-07-30 |
2003-03-20 |
Lone Jeppesen |
Novel compounds, their preparation and use
|
US7067530B2
(en)
|
2001-07-30 |
2006-06-27 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6869967B2
(en)
|
2001-07-30 |
2005-03-22 |
Novo Nordisk A/S |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
|
BRPI0211844B8
(pt)
*
|
2001-08-10 |
2021-05-25 |
Nippon Chemiphar Co |
composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
FR2830012B1
(fr)
*
|
2001-09-21 |
2003-10-31 |
Servier Lab |
Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharamaceutiques qui les contiennent
|
WO2003033493A1
(fr)
*
|
2001-10-12 |
2003-04-24 |
Nippon Chemiphar Co.,Ltd. |
Activateur du recepteur $g(d) active par le proliferateur de peroxisome
|
US7220877B2
(en)
|
2001-10-17 |
2007-05-22 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
SE0104333D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
ITRM20020016A1
(it)
*
|
2002-01-15 |
2003-07-15 |
Sigma Tau Ind Farmaceuti |
Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
|
US6716842B2
(en)
|
2002-04-05 |
2004-04-06 |
Warner-Lambert Company, Llc |
Antidiabetic agents
|
KR100621294B1
(ko)
*
|
2002-07-03 |
2006-09-06 |
에프. 호프만-라 로슈 아게 |
옥사졸 유도체 및 이의 인슐린 증감제로서의 용도
|
AU2003263814A1
(en)
*
|
2002-07-26 |
2004-02-16 |
Bayer Pharmaceuticals Corporation |
Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics
|
US8268352B2
(en)
*
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
EP1537091B1
(en)
*
|
2002-08-30 |
2010-10-06 |
F. Hoffmann-La Roche AG |
Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
|
RU2296759C2
(ru)
*
|
2002-09-12 |
2007-04-10 |
Ф.Хоффманн-Ля Рош Аг |
N-замещенные 1н-индол-5-пропионовые кислоты, фармацевтическая композиция, содержащая эти соединения, и их применение (варианты)
|
AR041481A1
(es)
|
2002-10-07 |
2005-05-18 |
Hoffmann La Roche |
Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
|
BR0316091A
(pt)
*
|
2002-11-08 |
2005-09-27 |
Hoffmann La Roche |
Compostos, processo para a manufatura dos mesmos, composições farmacêuticas, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas ppar(a) e/ou ppar(y) e/ou utilização dos mesmos
|
US20060142277A1
(en)
*
|
2002-11-15 |
2006-06-29 |
Cadila Healthcare Limited |
Substituted aralkyl derivatives
|
MXPA05005445A
(es)
*
|
2002-11-25 |
2005-08-26 |
Hoffmann La Roche |
Derivados de indolilo.
|
US7816385B2
(en)
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
CN1751037A
(zh)
*
|
2003-02-14 |
2006-03-22 |
伊莱利利公司 |
作为ppar调节剂的磺酰胺衍生物
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
EP1636183A1
(en)
*
|
2003-05-16 |
2006-03-22 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
US20040248972A1
(en)
*
|
2003-05-16 |
2004-12-09 |
Ambit Biosciences Corporation |
Compounds and uses thereof
|
WO2004106317A1
(ja)
|
2003-05-29 |
2004-12-09 |
The New Industry Research Organization |
ベンゾフラン化合物、およびそれを含有してなる医薬組成物
|
JP2005008631A
(ja)
*
|
2003-05-29 |
2005-01-13 |
New Industry Research Organization |
ベンゾフラン化合物、およびそれを含有してなる医薬組成物
|
GB0314131D0
(en)
*
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
GB2414294B
(en)
|
2004-05-20 |
2006-08-02 |
Teraview Ltd |
Apparatus and method for investigating a sample
|
KR101233223B1
(ko)
*
|
2004-12-21 |
2013-02-14 |
제이엔씨 석유 화학 주식회사 |
크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
|
BRPI0612396A2
(pt)
*
|
2005-07-06 |
2016-09-06 |
Nippon Chemiphar Co |
composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissoma delta
|
EP1976377A4
(en)
*
|
2006-01-25 |
2010-06-23 |
Wellstat Therapeutics Corp |
COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
|
CN102643248A
(zh)
*
|
2006-04-18 |
2012-08-22 |
日本化学医药株式会社 |
过氧化物酶体增殖剂激活受体δ的激活剂
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DK2277874T3
(en)
*
|
2008-04-15 |
2018-08-06 |
Nippon Chemiphar Co |
ACTIVATOR FOR PEROXISOM PROLIFERATOR-ACTIVATED RECEPTOR
|
CN102648025A
(zh)
*
|
2009-07-07 |
2012-08-22 |
火星工程有限公司 |
爆震波防止器
|
JP2013501812A
(ja)
*
|
2009-08-14 |
2013-01-17 |
セレニス セラピューティクス ホールディング エス.エー. |
炎症またはエネルギー代謝/産生関連疾患の治療または予防のためのPPARδリガンドの使用
|
GB201002243D0
(en)
*
|
2010-02-10 |
2010-03-31 |
Argenta Therapeutics Ltd |
Respiratory disease treatment
|
CN101941950B
(zh)
*
|
2010-08-05 |
2012-12-26 |
上海交通大学 |
2-取代苯并[d]噁唑-5-丙酸化合物及其制备和应用
|
HUE027512T2
(en)
|
2011-01-31 |
2016-10-28 |
Cadila Healthcare Ltd |
Treatment of lipodystrophy
|
UA114360C2
(uk)
|
2013-04-22 |
2017-05-25 |
Каділа Хелткере Лімітед |
Спосіб лікування та/або зменшення інтенсивності неалкогольної жирової хвороби печінки (нжхп)
|
US20160107989A1
(en)
|
2013-05-30 |
2016-04-21 |
Cadila Healthcare Limited |
A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
|
TW201513857A
(zh)
|
2013-07-05 |
2015-04-16 |
Cadila Healthcare Ltd |
協同性組成物
|
IN2013MU02470A
(he)
|
2013-07-25 |
2015-06-26 |
Cadila Healthcare Ltd |
|
WO2015033357A2
(en)
|
2013-09-06 |
2015-03-12 |
Cadila Healthcare Limited |
An improved process for the preparation of pyrrole derivatives
|
US10100042B2
(en)
|
2014-08-08 |
2018-10-16 |
Merck Sharp & Dohme Corp. |
[5,6]—fused bicyclic antidiabetic compounds
|
US10385017B2
(en)
|
2015-10-14 |
2019-08-20 |
Cadila Healthcare Limited |
Pyrrole compound, compositions and process for preparation thereof
|
BR112019011740A2
(pt)
|
2016-12-09 |
2019-10-29 |
Cadila Healthcare Ltd |
composição farmacêutica e método para o tratamento de colangite biliar primária
|